6‐Methoxy‐1‐tetralone Derivatives Bearing an N‐Arylpyridinium Moiety as Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Study-Reference-Cited by-同舟云学术

6‐Methoxy‐1‐tetralone Derivatives Bearing an N‐Arylpyridinium Moiety as Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Study

Published:2022-07-18 Issue:27 Volume:7 Page:
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Chehardoli Gholamabbas¹^ORCID,Gholamhoseini Pooriya²,Ebadi Ahmad¹,Ziaei Maral²,Akbarzadeh Tahmineh³⁴,Saeedi Mina⁴⁵,Mahdavi Mohammad⁶,Khoshneviszadeh Mehdi⁷,Najafi Zahra²^ORCID

Affiliation:

1. Department of Medicinal Chemistry School of Pharmacy Medicinal Plants and Natural Products Research Center Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran

2. Department of Medicinal Chemistry School of Pharmacy Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran

3. Department of Medicinal Chemistry Faculty of Pharmacy Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran

4. Persian Medicine and Pharmacy Research Center Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran

5. Medicinal Plants Research Center, Faculty of Pharmacy Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran

6. Endocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences 1411713137 Tehran Iran

7. Department of Medicinal Chemistry Faculty of Pharmacy Shiraz University of Medical Sciences 7146864685 Shiraz Iran

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202201977

Reference28 articles.

1. A Survey of Alzheimer’s Disease Early Diagnosis Methods for Cognitive Assessment

2. A review on Alzheimer's disease pathophysiology and its management: an update

3. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

4. Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy

5. The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands;European Journal of Medicinal Chemistry;2024-09

2. Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents;Journal of Molecular Structure;2023-08

3. Novel Pyrano[3,2-c]quinoline-1,2,3-triazole Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Molecular Dynamics Simulation;ACS Omega;2023-06-20

4. Fused 1,4‐Dihydropyridines and Their Corresponding Pyridines: Synthesis, Molecular Modeling and Cholinesterase Inhibition;ChemistrySelect;2023-05-15

5. Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation;RSC Advances;2023